GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Techno Drugs Ltd (DHA:TECHNODRUG) » Definitions » Other Net Income (Loss)

Techno Drugs (DHA:TECHNODRUG) Other Net Income (Loss) : BDT Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Techno Drugs Other Net Income (Loss)?

Techno Drugs's Other Net Income (Loss) for the three months ended in Dec. 2024 was BDT0 Mil. Techno Drugs does not have enough years/quarters to calculate its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024.

Techno Drugs's quarterly Other Net Income (Loss) declined from Dec. 2023 (BDT0 Mil) to Sep. 2024 (BDT0 Mil) but then stayed the same from Sep. 2024 (BDT0 Mil) to Dec. 2024 (BDT0 Mil).

Techno Drugs Other Net Income (Loss) Historical Data

The historical data trend for Techno Drugs's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Techno Drugs Other Net Income (Loss) Chart

Techno Drugs Annual Data
Trend
Other Net Income (Loss)

Techno Drugs Quarterly Data
Sep23 Dec23 Sep24 Dec24
Other Net Income (Loss) - - - -

Techno Drugs Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Techno Drugs Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Techno Drugs's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Techno Drugs Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Techno Drugs Ltd (DHA:TECHNODRUG) » Definitions » Other Net Income (Loss)
Comparable Companies
DHA:ASIATICLAB DHA:CENTRALPHL DHA:ORIONINFU DHA:ACMELAB ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA SHSE:688506 BOM:500087 SZSE:000538 TSE:4507 UTHR NSE:TORNTPHARM
Traded in Other Exchanges
N/A
Address
31 Segun Bagicha, J K Tower, Dhaka, BGD, 1000
Website
https://www.technodrugsltd.com
Techno Drugs Ltd is a pharmaceutical company. The company manufactures medicines for the healthcare market with quality products, a distribution channel, and doctor-patient acceptance. The company is also engaged in production of Anti-Cancer medicines and medicines for therapeutic areas like oncology, cardiovascular, diabetes, immune suppressor, anesthetics, life-saving antibiotics & contrast media in Bangladesh. The product portfolio of the company include Algicar Plus, Amoclav Forte, Adesol Oral Solution, Aminovet Injection, Apegestrol Tab, Docetex 20 Inj, and others.

Techno Drugs Headlines

No Headlines